Quotient Sciences on How AI Is Reshaping the CDMO–Sponsor Relationship

    As AI and digital technologies increasingly influence pharmaceutical development, CDMOs are taking on a broader role in helping sponsors im...

August 25, 2026 | Tuesday | Interaction
Milestone Pharmaceuticals Enrolls First Patient in Phase 3 Trial of Etripamil for AFib-RVR

Milestone® Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medi...

August 24, 2026 | Monday | News
Alvotech and Lotus Pharmaceutical Partner to Commercialize Two Biosimilar Candidates in U.S. and Asia

Alvotech , a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced a str...

August 24, 2026 | Monday | News
SK pharmteco Opens Expanded Manufacturing Facilities at Swords Campus in Ireland

SK pharmteco recently hosted a formal ribbon-cutting ceremony to mark the official opening of two major facility expansions at its manufacturing campus i...

August 20, 2026 | Thursday | News
Immunocine Cancer Center Opens Second Treatment Location in Cabo San Lucas

Responding to a growing number of patients seeking personalized cancer immunotherapy, Immunocine Cancer Center has opened a second treatment location in ...

August 20, 2026 | Thursday | News
Aurisco Pharmaceutical Passes USFDA Inspection as First Generic Oligonucleotide API Manufacturer

Aurisco Pharmaceutical, a leading global Oligonucleotide and Peptide (TIDES) manufacturer, announced that its site in Yangzhou, China has passed the USFDA ...

August 17, 2026 | Monday | News
Cycle Pharmaceuticals Partners With Forma to Manufacture CAVHANZA in U.S.

Cycle Pharmaceuticals (“Cycle”), a global pharmaceutical company focused on rare diseases, and Forma Life Sciences, Inc. (“Forma”...

August 14, 2026 | Friday | News
NurExone Signs MOU With Made Scientific for U.S. GMP Exosome Manufacturing Partnership

NurExone Biologic Inc. ("NurExone" or the "Company") (TSXV: NRX, OTCQB: NRXBF, FSE: J90), a biotechnology company developing exosome-based regenerative t...

August 14, 2026 | Friday | News
Fresenius Kabi Recalls Tyenne Injection Lot Over Glass Particle Contamination

Fresenius Kabi, an operating company of the Fresenius Group, is recalling one lot of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL)20 m...

August 12, 2026 | Wednesday | News
CellFiber and Tidewave Bio Collaborate to Advance Manufacturing of Off-the-Shelf Cell Therapy

CellFiber Co., Ltd. (“CellFiber”), a Tokyo-based biotechnology company built on its proprietary CellFiber® cell encapsulation platform, a...

August 07, 2026 | Friday | News
Building Confidence Beyond Compliance With Media Fills Designed for the Annex 1 Era

In the Annex 1 era, media fills must replicate the routine aseptic manufacturing process as closely as possible. This includes all critical manufacturing s...

August 03, 2026 | Monday | Expert Opinion
AGC Biologics Secures Multi-Year Commercial Manufacturing Agreement for Yokohama Facility

Reached a long-term business cooperation with a large pharmaceutical company to help it promote production licensing and commercial supervision and app...

July 30, 2026 | Thursday | News
Basilea Secures Additional USD 30 Million BARDA Funding for Phase 3 Antifungal Program

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bac...

July 29, 2026 | Wednesday | News
Accord BioPharma Launches Interchangeable Denosumab Biosimilars OSVYRTI and JUBEREQ in the U.S.

Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology and c...

July 27, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close